Mr. Carl Stacey Berg, MASTER OF SCIENCE MS Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1867 Williams Hwy, Suite 105, Grants Pass, OR 97527 Phone: 541-474-4694 Fax: 541-474-9590 |
Mr. Carl Jeffrey Berg, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1665 Williams Hwy, Grants Pass, OR 97527 Phone: 541-474-4694 |
Craig Berg, AU.D Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1665 Williams Hwy, Grants Pass, OR 97527 Phone: 541-474-4694 |
Dr. Samuel Nolan Peterson, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1867 Williams Hwy, Ste. 105, Grants Pass, OR 97527 Phone: 541-474-4694 Fax: 541-474-9590 |
Audiology Associates Of Southern Oregon, Inc. Audiologist Medicare: Medicare Enrolled Practice Location: 1665 Williams Hwy, Grants Pass, OR 97527 Phone: 541-474-4694 |
News Archive
According to the latest research from the Cancer Council, the incidence of bowel cancer in Australia is set to rise to 21,000 cases a year in the next decade. The report shows that one in five cases are diagnosed at an advanced stage, due to a lack of screening. This research is being used to renew the Federal Government's full funding and implementation of the national bowel cancer screening program. Funding for the program is due to expire at the end of June.
Nanion Technologies is pleased to announce the launch of the new SURFE2R 96SE Instrument for high throughput measurements of electrogenic membrane transporters and pumps.
The Fiscal Times reports on the rapidly growing number of people applying for Social Security retirement benefits and federal disability insurance because of the poor economy and job market. "Last year, applications totaled 2.6 million for retirement benefits and over 3 million for disability benefits — both representing modest increases over the previous year.
A surprising discovery about the physical properties of cancer cells could help improve a new diagnostic approach - a liquid biopsy - that detects, measures, and evaluates cancer cells in blood.
Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced the closing of its first financing, an $8 million private placement of the company's Series A Preferred Stock. Led by 5AM Ventures, other investors participating in the financing included Takeda Research Investment and Roche Venture Fund.
› Verified 4 days ago